EmailFacebookLinkedInTwitterGoogle+
Oxford Biotheraputics
Investors
Investors

Oxford BioTherapeutics has completed a number of successful investment rounds, and is supported by a syndicate of leading specialist investors. In addition to this equity funding, a significant proportion of the ongoing investment in our innovative antibody-based cancer therapies is generated through our strategic alliances with leading companies in the field. Our investors include a number of specialists:

Catapult Ventures
Oxford Capital
percipent_capital